Lipopolysaccharide preconditioning and cross-tolerance: The induction of protective mechanisms for rat intestinal ileus

Gastroenterology

Volumn 123, Issue 2, 2002, Pages 586-598

  Schwarz, Nicolas T ^a,b   Engel, Britta ^a,b   Eskandari, Mark K ^a,b   Kalff, Jörg C ^a,b   Grandis, Jennifer R ^a,b   Bauer, Anthony J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; ELECTROPHORETIC MOBILITY; GENE CONTROL; HISTOCHEMISTRY; ILEUS; INFLAMMATION; INTESTINE CONTRACTION; INTESTINE MOTILITY; INTESTINE MUSCLE; JEJUNUM; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036320301     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34777     Document Type: Article

References (61)

1. Objective estimates of the incidence and consequences of multiple organ dysfunction and sepsis after burn trauma
2. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity
3. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats
4. Intestinal cytokine response after gut ischemia: Role of gut barrier failure
5. The gut: A cytokine-generating organ in systemic inflammation
6. Trauma, shock, and gut translocation
7. A single dose of endotoxin increases intestinal permeability in healthy humans
8. Effects of endotoxin on regulation of intestinal smooth muscle nitric oxide synthase and intestinal transit
9. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide
10. Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide
11. Leukocytes of the intestinal muscularis: Their phenotype and isolation
12. Secretory products of macrophages
13. Endotoxin signal transduction in macrophages
14. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity
15. Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer
16. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS
17. Gastrointestinal transit during endotoxemia: The role of nitric oxide
18. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents
19. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS
20. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus
21. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus
22. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury
23. Impaired gut contractility following hemorrhagic shock is accompanied by IL-6 and G-CSF production and neutrophil infiltration
24. Prevention of experimental endotoxin shock by a monocyte activator
25. Possible roles for anti- or pro-inflammatory therapies in the management of sepsis
26. Molecular mechanism in tolerance to lipopolysaccharide
27. Pharmacological preconditioning with lipopolysaccharide in the brain
28. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density
29. LPS-induced delayed myocardial adaptation enhances acute preconditioning to optimize postischemic cardiac function
30. Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology
31. Ischaemic preconditioning of the vasculature: An overlooked phenomenon for protecting the heart?
32. Do transient ischemic attacks have a neuroprotective effect?
33. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat
34. Development of ischemia/reperfusion tolerance in the rat small intestine. An epithelium-independent event
35. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation
36. Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits
37. Preconditioning for protection from ischemic injury: Discriminating cause from effect from epiphenomenon
38. Endotoxin cross tolerance: Another inflammatory preconditioning stimulus?
39. Therapeutic potential of ischaemic preconditioning
40. Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning
41. Ischemic preconditioning: From basic mechanisms to clinical applications
42. Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection
43. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat
44. Accurate measurement of intestinal transit in the rat
45. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock
46. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance
47. Dysregulation of in vitro cytokine production by monocytes during sepsis
48. Laparoscopic surgery and the systemic immune response
49. Changes in intestinal transit and absorption during endotoxemia are dose dependent
50. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity
51. Effects of lipopolysaccharide priming on acute ischemic brain injury
52. Inhibitory κBα control of nuclear factor-κB is dysregulated in endotoxin tolerant macrophages
53. Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis
54. NF-kB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression
55. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers
56. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide
57. Interleukin-10 is upregulated in LPS tolerance
58. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils
59. Interleukin 8 production in whole blood assays: Is interleukin 10 responsible for the downregulation observed in sepsis?
60. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats
61. Preconditioning improves function and recovery of single muscle fibres during severe hypoxia and reoxygenation